Allogene Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Allogene Therapeutics, Inc. (ALLO) reported Increase (Decrease) in Other Noncurrent Assets of $82.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-12
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $166.00K, a 91.39% decline year-over-year.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$84.00K.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $102.00K.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$315.00K.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $1.29M.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was -$4.28M, a 394.09% decline from fiscal 2023.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $1.46M, a 56.36% decline from fiscal 2022.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was $3.33M, a 416.10% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 1 month | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $82.00K 10-Q · filed 2026-08-12 | $184.00K derived: sum of 3 quarters · filed 2026-08-12 | -$131.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$84.00K 10-Q · filed 2026-05-13 | $18.00K derived: sum of 2 quarters · filed 2026-05-13 | -$297.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.63M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$213.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.72M derived: sum of 3 quarters · filed 2026-08-12 | $1.29M 10-K · filed 2026-03-12 | |
| 2025-09-30 | -$315.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.61M derived: sum of 2 quarters · filed 2026-08-12 | $1.19M 10-Q · filed 2025-11-06 | $500.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.50M 10-Q · filed 2026-08-12 | $815.00K derived: sum of 3 quarters · filed 2026-08-12 | -$654.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$425.00K 10-Q · filed 2026-05-13 | -$1.11M derived: sum of 2 quarters · filed 2026-05-13 | -$2.58M derived: sum of 3 quarters · filed 2026-05-13 | -$3.26M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$688.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$2.16M derived: sum of 2 quarters · filed 2026-03-12 | -$2.83M derived: sum of 3 quarters · filed 2026-03-12 | -$4.28M 10-K · filed 2026-03-12 | |
| 2024-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.15M derived: sum of 2 quarters · filed 2025-11-06 | -$3.59M 10-Q · filed 2025-11-06 | -$2.56M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | -$677.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$2.12M 10-Q · filed 2025-08-13 | -$1.09M derived: sum of 3 quarters · filed 2025-08-13 | -$722.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$1.45M 10-Q · filed 2025-05-13 | -$411.00K derived: sum of 2 quarters · filed 2025-05-13 | -$45.00K derived: sum of 3 quarters · filed 2025-05-13 | $55.00K derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $1.40M derived: sum of 2 quarters · filed 2025-03-13 | $1.50M derived: sum of 3 quarters · filed 2025-03-13 | $1.46M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $366.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $466.00K derived: sum of 2 quarters · filed 2024-11-07 | $421.00K 10-Q · filed 2024-11-07 | $544.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $55.00K 10-Q · filed 2024-08-07 | $178.00K derived: sum of 3 quarters · filed 2024-08-07 | $586.00K derived: sum of 4 quarters · filed 2024-08-07 | |
| 2023-03-31 | -$45.00K 10-Q · filed 2024-05-13 | $78.00K derived: sum of 2 quarters · filed 2024-05-13 | $486.00K derived: sum of 3 quarters · filed 2024-05-13 | $175.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $123.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-14 | $531.00K derived: sum of 2 quarters · filed 2024-03-14 | $220.00K derived: sum of 3 quarters · filed 2024-03-14 | $3.33M 10-K/A · filed 2024-03-14 | |
| 2022-09-30 | $408.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $97.00K derived: sum of 2 quarters · filed 2023-11-02 | $3.21M 10-Q · filed 2023-11-02 | $2.87M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-06-30 | -$311.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.80M 10-Q · filed 2023-08-02 | $2.46M derived: sum of 3 quarters · filed 2024-03-14 | $2.79M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-03-31 | $3.11M 10-Q · filed 2023-05-03 | $2.77M derived: sum of 2 quarters · filed 2024-03-14 | $3.10M derived: sum of 3 quarters · filed 2024-03-14 | $2.96M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2021-12-31 | -$345.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-14 | -$14.00K derived: sum of 2 quarters · filed 2024-03-14 | -$153.00K derived: sum of 3 quarters · filed 2024-03-14 | $646.00K 10-K/A · filed 2024-03-14 | |
| 2021-09-30 | $331.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $192.00K derived: sum of 2 quarters · filed 2022-11-02 | $991.00K 10-Q · filed 2022-11-02 | $2.93M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2021-06-30 | -$139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $660.00K 10-Q · filed 2022-08-09 | $2.60M derived: sum of 3 quarters · filed 2024-03-14 | $3.08M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2021-03-31 | $799.00K 10-Q · filed 2022-05-04 | $2.74M derived: sum of 2 quarters · filed 2024-03-14 | $3.22M derived: sum of 3 quarters · filed 2024-03-14 | $708.00K derived: sum of 4 quarters · filed 2024-03-14 | |
| 2020-12-31 | $1.94M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-14 | $2.42M derived: sum of 2 quarters · filed 2024-03-14 | -$91.00K derived: sum of 3 quarters · filed 2024-03-14 | -$34.00K 10-K/A · filed 2024-03-14 | |
| 2020-09-30 | $483.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$2.03M derived: sum of 2 quarters · filed 2021-11-04 | -$1.98M 10-Q · filed 2021-11-04 | -$464.00K derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-06-30 | -$2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$2.46M 10-Q · filed 2021-08-04 | -$947.00K derived: sum of 3 quarters · filed 2022-02-23 | -$77.00K derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-03-31 | $57.00K 10-Q · filed 2021-05-05 | $1.57M derived: sum of 2 quarters · filed 2022-02-23 | $2.44M derived: sum of 3 quarters · filed 2022-02-23 | $4.24M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2019-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $2.38M derived: sum of 2 quarters · filed 2022-02-23 | $4.19M derived: sum of 3 quarters · filed 2022-02-23 | $4.37M 10-K · filed 2022-02-23 | |
| 2019-09-30 | $870.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $2.67M derived: sum of 2 quarters · filed 2020-11-04 | $2.86M 10-Q · filed 2020-11-04 | $1.64M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.99M 10-Q · filed 2020-08-05 | $769.00K derived: sum of 3 quarters · filed 2021-02-25 | $2.24M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $188.00K 10-Q · filed 2020-05-06 | -$1.04M derived: sum of 2 quarters · filed 2021-02-25 | $432.00K derived: sum of 3 quarters · filed 2021-02-25 | $432.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $244.00K derived: sum of 2 quarters · filed 2021-02-25 | $244.00K derived: sum of 3 quarters · filed 2021-02-25 | $244.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.47M derived: sum of 2 quarters · filed 2019-11-05 | $1.47M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |